GleamWall
中文EN

MPM BIOIMPACT LLC

BOSTON MA · SEC CIK 0001687078

2026Q22026Q1 9 earlier quarters 🔒
$1.64B2026Q2 reported value
37Positions
55.3%Top 10 weight · largest 10.8%
7 / 11New / sold out
Reported value over time$1.64B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

CGEM 10.8%
AKTS 9.5%
LQDA 6.7%
RVMD 5.6%
CORT 4.1%
EWTX 4.0%
TVTX 3.9%
DBVT 3.7%
TRVI 3.5%
ALMS 3.5%

2026Q2 top buys estimated at quarter-end value

RARE New+$47.35M
BIOA New+$40.87M
CGEM Added+$37.93M
TSHA New+$30.64M
ABVX Added+$30.53M

2026Q2 top sells estimated at quarter-end value

AGIO Sold out-$44.19M
XENE Sold out-$34.23M
EVMN Sold out-$33.47M
CYTK Sold out-$32.95M
DBVT Reduced-$25.37M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
CGEM Cullinan Therapeutics, Inc. $177.21M10.81%9,731,341 2,083,07327.2% $37.93M Added
AKTS Aktis Oncology, Inc. $155.86M9.50%4,835,872 00.0% — Unchanged
LQDA Liquidia Corporation $110.52M6.74%1,386,174 -18,984-1.4% -$1.51M Reduced
RVMD Revolution Medicines, Inc. $92.23M5.62%492,483 -14,293-2.8% -$2.68M Reduced
CORT Corcept Therapeutics, Inc. $67.04M4.09%771,028 -214,672-21.8% -$18.67M Reduced
EWTX Edgewise Therapeutics Inc $65.85M4.02%1,620,780 -39,916-2.4% -$1.62M Reduced
TVTX Travere Therapeutics Inc $63.78M3.89%1,122,731 -10,634-0.9% -$604,118 Reduced
DBVT DBV Technologies S A $60.13M3.67%3,666,284 -1,547,077-29.7% -$25.37M Reduced
TRVI Trevi Therapeutics Inc $57.32M3.50%3,073,577 -224,853-6.8% -$4.19M Reduced
ALMS Alumis Inc $56.82M3.46%2,019,020 -367,509-15.4% -$10.34M Reduced
QURE Uniqure NV $56.46M3.44%1,225,855 -143,376-10.5% -$6.60M Reduced
RARE Ultragenyx Pharmaceuticals, Inc. $47.35M2.89%1,418,215 1,418,215— $47.35M New
RLAY Relay Therapeutics Inc. $45.20M2.76%2,415,672 56,0862.4% $1.05M Added
ABVX Abivax SA $44.82M2.73%336,347 229,079213.6% $30.53M Added
DYN Dyne Therapeutics, Inc. $42.69M2.60%1,922,093 513,94136.5% $11.41M Added
DNTH Dianthus Therapeutics Inc $40.94M2.50%420,002 -3,980-0.9% -$387,970 Reduced
BIOA BIOAGE Labs Inc $40.87M2.49%1,667,661 1,667,661— $40.87M New
URGN Urogen Pharma Ltd $34.35M2.09%933,415 -10,388-1.1% -$382,278 Reduced
MLTX MoonLake Immunotherapeutics $31.29M1.91%1,606,967 -204,115-11.3% -$3.97M Reduced
PVLA Palvella Therapeutics Inc $31.18M1.90%204,027 -2,377-1.2% -$363,253 Reduced
TSHA Taysha Gene Therapies, Inc. $30.64M1.87%4,500,000 4,500,000— $30.64M New
SNDX Syndax Pharmaceuticals Inc $29.15M1.78%1,333,523 -7,210-0.5% -$157,611 Reduced
GLUE Monte Rosa Therapeutics Inc $28.10M1.71%1,161,081 -15,847-1.3% -$383,497 Reduced
ZURA Zura Bio Ltd. $26.39M1.61%4,472,843 4,472,843— $26.39M New
NTRA Natera Inc $25.15M1.53%92,638 -436-0.5% -$118,352 Reduced
STOK Stoke Therapeutics Inc $23.67M1.44%723,314 -43,724-5.7% -$1.43M Reduced
ANL Adlai Nortye Ltd $22.27M1.36%1,936,291 1,936,291— $22.27M New
BLTE Belite Bio Inc $21.13M1.29%137,208 49,16355.8% $7.57M Added
— Forte Biosciences, Inc. $20.98M1.28%987,448 -13,234-1.3% -$281,222 Reduced
ORIC Oric Pharmaceuticals Inc $20.38M1.24%1,882,162 78,2174.3% $847,090 Added
TARS Tarsus Pharmaceuticals Inc $20.27M1.24%322,007 -7,743-2.3% -$487,344 Reduced
ANNX Annexon Inc $20.24M1.23%3,544,354 3,544,354— $20.24M New
DRUG Bright Minds Biosciences Inc $14.19M0.87%202,114 -10,061-4.7% -$706,282 Reduced
TRDA Entrada Therapeutics, Inc. $9.22M0.56%1,253,053 1,253,053— $9.22M New
ACRS Aclaris Therapeutics Inc $5.51M0.34%1,042,467 650,549166.0% $3.44M Added
— Context Therapeutics Inc $719,5420.04%1,299,046 -9,380,345-87.8% -$5.20M Reduced
— Werewolf Therapeutics, Inc. $28,8510.00%80,142 -1,128,668-93.4% -$406,319 Reduced
AGIO Agios Pharmaceuticals Inc $00.00%0 -1,306,261-100.0% -$44.19M Sold out
XENE Xenon Pharmaceuticals Inc $00.00%0 -588,706-100.0% -$34.23M Sold out
EVMN Evommune Inc $00.00%0 -1,455,863-100.0% -$33.47M Sold out
CYTK Cytokinetics Inc $00.00%0 -500,000-100.0% -$32.95M Sold out
CRVS Corvus Pharmaceuticals Inc $00.00%0 -1,674,875-100.0% -$24.50M Sold out
CLYM Climb Bio Inc $00.00%0 -2,593,439-100.0% -$17.77M Sold out
ARQT Arcutis Biotherapeutics Inc $00.00%0 -733,966-100.0% -$17.29M Sold out
ZYME Zymeworks, Inc. $00.00%0 -565,249-100.0% -$14.15M Sold out
VRDN Viridian Therapeutics Inc $00.00%0 -649,873-100.0% -$12.71M Sold out
— enGene Holdings, Inc. $00.00%0 -1,845,373-100.0% -$12.57M Sold out
ALLO Allogene Therapeutics, Inc. $00.00%0 -2,242,933-100.0% -$5.47M Sold out